Projected Income Statement: Northrop Grumman Corporation

Forecast Balance Sheet: Northrop Grumman Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 9,247 9,228 10,677 10,339 10,759 8,660 8,218 7,893
Change - -0.21% 15.7% -3.17% 4.06% -19.51% -5.1% -3.95%
Announcement Date 27/01/22 26/01/23 25/01/24 30/01/25 27/01/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Northrop Grumman Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 1,415 1,435 1,775 1,767 1,450 1,828 2,098 2,175
Change - 1.41% 23.69% -0.45% -17.94% 26.04% 14.8% 3.64%
Free Cash Flow (FCF) 1 2,152 1,466 2,100 2,621 3,307 3,335 3,424 3,713
Change - -31.88% 43.25% 24.81% 26.17% 0.84% 2.66% 8.44%
Announcement Date 27/01/22 26/01/23 25/01/24 30/01/25 27/01/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Northrop Grumman Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 19.32% 13.5% 13.57% 13.99% 14.26% 14.14% 14.13% 14.21%
EBIT Margin (%) 15.84% 9.84% 10.16% 10.65% 10.75% 10.56% 10.69% 10.84%
EBT Margin (%) 25.06% 15.94% 5.97% 12.22% 12.08% 10.93% 10.94% 11.12%
Net margin (%) 19.64% 13.38% 5.23% 10.17% 9.97% 9.06% 9.04% 9.19%
FCF margin (%) 6.03% 4.01% 5.34% 6.39% 7.88% 7.58% 7.31% 7.46%
FCF / Net Income (%) 30.72% 29.94% 102.14% 62.79% 79.08% 83.69% 80.78% 81.19%

Profitability

        
ROA 9.47% 9.21% 5.37% 8.7% 8.3% 7.64% 7.82% 8.07%
ROE 35.08% 28.15% 13.66% 27.75% 26.17% 22.2% 21.36% 21.27%

Financial Health

        
Leverage (Debt/EBITDA) 1.34x 1.87x 2x 1.8x 1.8x 1.39x 1.24x 1.12x
Debt / Free cash flow 4.3x 6.29x 5.08x 3.94x 3.25x 2.6x 2.4x 2.13x

Capital Intensity

        
CAPEX / Current Assets (%) 3.97% 3.92% 4.52% 4.31% 3.46% 4.15% 4.48% 4.37%
CAPEX / EBITDA (%) 20.54% 29.03% 33.3% 30.78% 24.24% 29.39% 31.69% 30.76%
CAPEX / FCF (%) 65.75% 97.89% 84.52% 67.42% 43.85% 54.81% 61.29% 58.58%

Items per share

        
Cash flow per share 1 13.37 18.64 13.82 17.79 33.08 35.03 39.96 42.33
Change - 39.4% -25.9% 28.79% 85.91% 5.88% 14.09% 5.94%
Dividend per Share 1 6.16 6.76 7.34 8.05 - 9.699 10.53 11.29
Change - 9.74% 8.58% 9.67% - - 8.59% 7.15%
Book Value Per Share 1 82.86 99.98 98.56 105.5 117.4 133.8 141.7 150.5
Change - 20.66% -1.41% 7.02% 11.32% 13.97% 5.89% 6.23%
EPS 1 43.54 31.47 13.53 28.34 29.08 27.98 29.89 32.43
Change - -27.72% -57.01% 109.46% 2.61% -3.79% 6.83% 8.52%
Nbr of stocks (in thousands) 158,538 153,912 150,793 145,695 142,720 142,033 142,033 142,033
Announcement Date 27/01/22 26/01/23 25/01/24 30/01/25 27/01/26 - - -
1USD
Estimates
2026 *2027 *
P/E 19.3x 18.1x
PBR 4.03x 3.81x
EV / Sales 1.94x 1.81x
Yield 1.8% 1.95%

EPS & Dividend

Y-o-Y evolution of P/E

Year-on-year evolution of the Yield

Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
539.63USD
Average target price
687.14USD
Spread / Average Target
+27.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOC Stock
  4. Financials Northrop Grumman Corporation